These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34891386)

  • 21. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People.
    Konig A; Satt A; Sorin A; Hoory R; Derreumaux A; David R; Robert PH
    Curr Alzheimer Res; 2018; 15(2):120-129. PubMed ID: 28847279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
    Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
    Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.
    Binaco R; Calzaretto N; Epifano J; McGuire S; Umer M; Emrani S; Wasserman V; Libon DJ; Polikar R
    J Int Neuropsychol Soc; 2020 Aug; 26(7):690-700. PubMed ID: 32200771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Domain transfer learning for MCI conversion prediction.
    Cheng B; Zhang D; Shen D
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 1):82-90. PubMed ID: 23285538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer's disease.
    Huang L; Chen KL; Lin BY; Tang L; Zhao QH; Lv YR; Guo QH
    Neuropsychiatr Dis Treat; 2018; 14():2133-2140. PubMed ID: 30174426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity and Cultural Generalisability of a 5-Minute AI-Based, Computerised Cognitive Assessment in Mild Cognitive Impairment and Alzheimer's Dementia.
    Kalafatis C; Modarres MH; Apostolou P; Marefat H; Khanbagi M; Karimi H; Vahabi Z; Aarsland D; Khaligh-Razavi SM
    Front Psychiatry; 2021; 12():706695. PubMed ID: 34366938
    [No Abstract]   [Full Text] [Related]  

  • 34. [Time-sparing screening method for mild cognitive impairment and early Alzheimer's disease: Self- and family reports using the TMIG index of competence].
    Akasaka H; Yonezawa H; Takahashi J; Obara S; Shibata T; Suzuki M; Ishizuka N; Sato M; Kudo M; Terayama Y; Maeda T
    Nihon Ronen Igakkai Zasshi; 2020; 57(2):182-194. PubMed ID: 32475946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis.
    Tsai CF; Lee WJ; Wang SJ; Shia BC; Nasreddine Z; Fuh JL
    Int Psychogeriatr; 2012 Apr; 24(4):651-8. PubMed ID: 22152127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Mini-Addenbrooke's Cognitive Examination (M-ACE) as a brief cognitive screening instrument in Mild Cognitive Impairment and mild Alzheimer's disease.
    Miranda DDC; Brucki SMD; Yassuda MS
    Dement Neuropsychol; 2018; 12(4):368-373. PubMed ID: 30546846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.